Exploration of the Performance of a Hybrid Closed Loop Insulin Delivery Algorithm That Includes Insulin Delivery Limits Designed to Protect Against Hypoglycemia

Martin de Bock, Julie Dart, Anirban Roy, Raymond Davey, Wayne Soon, Carolyn Berthold, Adam Retterath, Benyamin Grosman, Natalie Kurtz, Elizabeth Davis, Timothy Jones, Martin de Bock, Julie Dart, Anirban Roy, Raymond Davey, Wayne Soon, Carolyn Berthold, Adam Retterath, Benyamin Grosman, Natalie Kurtz, Elizabeth Davis, Timothy Jones

Abstract

Background: Hypoglycemia remains a risk for closed loop insulin delivery particularly following exercise or if the glucose sensor is inaccurate. The aim of this study was to test whether an algorithm that includes a limit to insulin delivery is effective at protecting against hypoglycemia under those circumstances.

Methods: An observational study on 8 participants with type 1 diabetes was conducted, where a hybrid closed loop system (HCL) (Medtronic™ 670G) was challenged with hypoglycemic stimuli: exercise and an overreading glucose sensor.

Results: There was no overnight or exercise-induced hypoglycemia during HCL insulin delivery. All daytime hypoglycemia was attributable to postmeal bolused insulin in those participants with a more aggressive carbohydrate factor.

Conclusion: HCL systems rely on accurate carbohydrate ratios and carbohydrate counting to avoid hypoglycemia. The algorithm that was tested against moderate exercise and an overreading glucose sensor performed well in terms of hypoglycemia avoidance. Algorithm refinement continues in preparation for long-term outpatient trials.

Keywords: closed loop; continuous glucose monitoring; hypoglycemia; type 1 diabetes.

Conflict of interest statement

Declaration of Conflicting Interests: The author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: MDB reported he was supported by the Juvenile Diabetes Research Foundation mentored fellowship, and had received honoraria for scientific lectures (Medtronic) and travel reimbursement by Novo-Nordisk and the Juvenile Diabetes Research Foundation mentored fellowship. TJ reported receiving honoraria for scientific lectures and travel reimbursement from Medtronic, Sanofi-aventis, Eli Lilly, and Novo-Nordisk. AR, BG, and NK are employees of Medtronic.

Figures

Figure 1.
Figure 1.
Study protocol flow diagram.

Source: PubMed

3
Se inscrever